Recombinant Human Cytomegalovirus (HCMV) RL13 Binds Human Immunoglobulin G Fc

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Cortese, Mirko ^a   Calò, Stefano ^a   D'Aurizio, Romina ^a   Lilja, Anders ^b   Pacchiani, Nicola ^a   Merola, Marcello ^a,c  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b Clinical Research and Development   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BINDING PROTEIN; HUMAN CYTOMEGALOVIRUS RL13 PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; PHENYLALANINE; TYROSINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; ENDOCYTOSIS; EPITHELIUM CELL; GENETIC TRANSFECTION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE EVASION; INTERNALIZATION; MEMBRANE BINDING; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; VIROGENESIS;

AMINO ACID SEQUENCE; CELL LINE; CELL MEMBRANE; CYTOMEGALOVIRUS; HUMANS; IMMUNE EVASION; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PLASMIDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; REASSORTANT VIRUSES; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION; VIRAL PROTEINS;

HUMAN HERPESVIRUS 5;

EID: 84870627128     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050166     Document Type: Article

References (43)

1. Mocarski ES, Shenk T, Pass RF (2007) Cytomegaloviruses. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia, PA: Lippincott Williams & Wilkins. pp. 2701-2772.
2. Britt W, (2008) Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Current topics in microbiology and immunology 325: 417-470.
3. Murphy E, Shenk T, (2008) Human cytomegalovirus genome. Current topics in microbiology and immunology 325: 1-19.
4. Akter P, Cunningham C, McSharry BP, Dolan A, Addison C, et al. (2003) Two novel spliced genes in human cytomegalovirus. J Gen Virol 84: 1117-1122.
5. Dargan DJ, Douglas E, Cunningham C, Jamieson F, Stanton RJ, et al. (2010) Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J Gen Virol 91: 1535-1546.
6. Stanton RJ, Baluchova K, Dargan DJ, Cunningham C, Sheehy O, et al. (2010) Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J Clin Invest 120: 3191-3208.
7. Powers C, DeFilippis V, Malouli D, Fruh K, (2008) Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 325: 333-359.
8. Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL, (2000) Viral subversion of the immune system. Annu Rev Immunol 18: 861-926.
9. Hook LM, Friedman HM (2007) Subversion of innate and adaptive immunity: immune evasion from antibody and complement. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, et al., editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge, UK: Cambridge University Press. pp. 1137-1152.
10. Nimmerjahn F, Ravetch JV, (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8: 34-47.
11. Atalay R, Zimmermann A, Wagner M, Borst E, Benz C, et al. (2002) Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 76: 8596-8608.
12. Lilley BN, Ploegh HL, Tirabassi RS, (2001) Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J Virol 75: 11218-11221.
13. Sprague ER, Reinhard H, Cheung EJ, Farley AH, Trujillo RD, et al. (2008) The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G. J Virol. 82: 3490-3499.
14. Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, et al. (2003) Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A 100: 14976-14981.
15. Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, et al. (2004) Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol 78: 10960-10966.
16. Davison AJ, Dolan A, Akter P, Addison C, Dargan DJ, et al. (2003) The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J Gen Virol 84: 17-28.
17. Sekulin K, Gorzer I, Heiss-Czedik D, Puchhammer-Stockl E, (2007) Analysis of the variability of CMV strains in the RL11D domain of the RL11 multigene family. Virus Genes 35: 577-583.
18. Bonifacino JS, Traub LM, (2003) Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 72: 395-447.
19. Letunic I, Doerks T, Bork P, (2009) SMART 6: recent updates and new developments. Nucleic Acids Res 37: D229-D232.
20. Dolan A, Cunningham C, Hector RD, Hassan-Walker AF, Lee L, et al. (2004) Genetic content of wild-type human cytomegalovirus. J Gen Virol 85: 1301-1312.
21. Dubin G, Frank I, Friedman HM, (1990) Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes. J Virol 64: 2725-2731.
22. Para MF, Goldstein L, Spear PG, (1982) Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein. J Virol 41: 137-144.
23. Litwin V, Jackson W, Grose C, (1992) Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J Virol 66: 3643-3651.
24. Van de Walle GR, Favoreel HW, Nauwynck HJ, Pensaert MB, (2003) Antibody-induced internalization of viral glycoproteins and gE-gI Fc receptor activity protect pseudorabies virus-infected monocytes from efficient complement-mediated lysis. J Gen Virol 84: 939-948.
25. Thale R, Lucin P, Schneider K, Eggers M, Koszinowski UH, (1994) Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J Virol 68: 7757-7765.
26. Frank I, Friedman HM, (1989) A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J Virol. 63: 4479-4488.
27. Sprague ER, Wang C, Baker D, Bjorkman PJ, (2006) Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging. PLoS Biol 4: e148.
28. Lichtenstein DL, Krajcsi P, Esteban DJ, Tollefson AE, Wold WS, (2002) Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosis. J Virol 76: 11329-11342.
29. Pan Q, Hammarstrom L, (2000) Molecular basis of IgG subclass deficiency. Immunol Rev 178: 99-110.
30. Gordon CL, Johnson PD, Permezel M, Holmes NE, Gutteridge G, et al. (2010) Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis 50: 672-678.
31. Chan JF, To KK, Tse H, Lau CC, Li IW, et al. (2011) The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation. Clin Vaccine Immunol 18: 305-310.
32. Schneider-Merck T, Lammerts van Bueren JJ, Berger S, Rossen K, Berkel PH, et al. (2010) Human IgG2 antibodies against epidermal growth factor receptor effectively trigger antibody-dependent cellular cytotoxicity but, in contrast to IgG1, only by cells of myeloid lineage. J Immunol 184: 512-520.
33. Reeves M, Sinclair J, (2008) Aspects of human cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol 325: 297-313.
34. Wang F, Tang W, McGraw HM, Bennett J, Enquist LW, et al. (2005) Herpes simplex virus type 1 glycoprotein e is required for axonal localization of capsid, tegument, and membrane glycoproteins. J Virol 79: 13362-13372.
35. Weeks BS, Sundaresan P, Nagashunmugam T, Kang E, Friedman HM, (1997) The herpes simplex virus-1 glycoprotein E (gE) mediates IgG binding and cell-to-cell spread through distinct gE domains. Biochem Biophys Res Commun 235: 31-35.
36. Moorman NJ, Sharon-Friling R, Shenk T, Cristea IM, (2010) A targeted spatial-temporal proteomics approach implicates multiple cellular trafficking pathways in human cytomegalovirus virion maturation. Mol Cell Proteomics 9: 851-860.
37. Rice P, Longden I, Bleasby A, (2000) EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 16: 276-277.
38. Lipman DJ, Pearson WR, (1985) Rapid and sensitive protein similarity searches. Science 227: 1435-1441.
39. Mulder N, Apweiler R, (2007) InterPro and InterProScan: tools for protein sequence classification and comparison. Methods Mol Biol 396: 59-70.
40. Taly JF, Magis C, Bussotti G, Chang JM, Di TP, et al. (2011) Using the T-Coffee package to build multiple sequence alignments of protein, RNA, DNA sequences and 3D structures. Nat Protoc 6: 1669-1682.
41. Kall L, Krogh A, Sonnhammer EL, (2004) A combined transmembrane topology and signal peptide prediction method. J Mol Biol 338: 1027-1036.
42. Jones DT, (1999) Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol 292: 195-202.
43. Julenius K, Molgaard A, Gupta R, Brunak S, (2005) Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 15: 153-164.